The injectable HIV treatment cabotegravir is set to become more widely available in sub-Saharan Africa following a new licensing agreement.

Sanofi has joined the ‘Beacon of Hope’ programme – a Novartis initiative seeking to address racial inequality in clinical trials, health and education and to create greater diversity across R&D structures.

The Association of the British Pharmaceutical Industry (ABPI) has been awarded PIF TICK trusted healthcare information creator status by the Patient Information Forum, in recognition of its commitment to providing clear, accurate information for patients and the public

In its annual Palio meeting, GSK discusses the growing threat to human health from infectious disease with a group of experts in immunology, vaccinology and epidemiology.

CEPI, Gavi and WHO have announced a collective effort to support the Ugandan Government’s response to the recent Ebolavirus outbreak.

Chronic kidney disease is present in one in 10 adults, according to a recent study by AstraZeneca. Read the article for more details.

A new CVD initiative has been launched by Novartis UK to drive innovation and improve patient access to prevention solutions.

Sanofi is set to cut the pricing of its insulin products in a massive step toward greater access to medicine in the US. Read to find out more.